Catalyst Wire Dossier Catalyst Wire Dossier

BXCL501

dexmedetomidine · BioXcel Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BXCL501, covering 2023-08-25 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: BXCL501 After Stress to Increase Recovery Success [Phase 2]

See pricing